FDA Okays New Cetuximab Indication For Late-Stage Head and Neck Cancer

2011 ◽  
Vol 42 (12) ◽  
pp. 15
Author(s):  
ELIZABETH MECHCATIE
2011 ◽  
Vol 93 (6) ◽  
pp. 217-220 ◽  
Author(s):  
S Haikel ◽  
N Dawe ◽  
G Lekakis ◽  
M Black ◽  
D Mitchell

In 1998 the UK government published its white paper The New NHS: Modern and Dependable, in which it first suggested that patients being referred with a suspicion of cancer should have a maximum wait of two weeks to see a specialist. The rationale for this was that outcomes for late-stage disease are significantly worse when compared with outcomes for early-stage disease (Table 1). It was assumed that reducing the wait to see a specialist would reduce the stage of disease at presentation.


BMJ ◽  
2021 ◽  
pp. n1194
Author(s):  
Euan D Mackinnon ◽  
Sangeetha Sornalingam ◽  
Max Cooper

Cancer ◽  
2019 ◽  
Vol 126 (5) ◽  
pp. 1090-1101 ◽  
Author(s):  
Adam Thompson‐Harvey ◽  
Mahi Yetukuri ◽  
Alec R. Hansen ◽  
Matthew C. Simpson ◽  
Eric Adjei Boakye ◽  
...  

1998 ◽  
Vol 23 (4) ◽  
pp. 376-376
Author(s):  
Quak ◽  
Van Bokhorst ◽  
Klop ◽  
Van Leeuwen ◽  
Snow

Sign in / Sign up

Export Citation Format

Share Document